Literature DB >> 11368061

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

B K Adler, D E Salzman, M H Carabasi, W P Vaughan, V V Reddy, J T Prchal.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11368061     DOI: 10.1182/blood.v97.10.3313

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  47 in total

Review 1.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease.

Authors:  Vicky Chaar; Julien Picot; Olivier Renaud; Pablo Bartolucci; Ruben Nzouakou; Dora Bachir; Frédéric Galactéros; Yves Colin; Caroline Le Van Kim; Wassim El Nemer
Journal:  Haematologica       Date:  2010-06-18       Impact factor: 9.941

Review 3.  The paradox of the neutrophil's role in tissue injury.

Authors:  George B Segel; Marc W Halterman; Marshall A Lichtman
Journal:  J Leukoc Biol       Date:  2010-11-19       Impact factor: 4.962

4.  Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

Authors:  Evangelia Yannaki; Thalia Papayannopoulou; Erica Jonlin; Fani Zervou; Garyfalia Karponi; Angeliki Xagorari; Pamela Becker; Nikoleta Psatha; Ioannis Batsis; Panayotis Kaloyannidis; Varvara Tahynopoulou; Varnavas Constantinou; Asimina Bouinta; Konstantia Kotta; Aglaia Athanassiadou; Achilles Anagnostopoulos; Athanasios Fassas; George Stamatoyannopoulos
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

Review 5.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 6.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

7.  AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

Authors:  André Larochelle; Allen Krouse; Mark Metzger; Donald Orlic; Robert E Donahue; Simon Fricker; Gary Bridger; Cynthia E Dunbar; Peiman Hematti
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

Review 8.  Gene therapy for hemoglobinopathies: the state of the field and the future.

Authors:  Shanmuganathan Chandrakasan; Punam Malik
Journal:  Hematol Oncol Clin North Am       Date:  2014-04       Impact factor: 3.722

Review 9.  Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.

Authors:  Valentina Ghiaccio; Maxwell Chappell; Stefano Rivella; Laura Breda
Journal:  Mol Diagn Ther       Date:  2019-04       Impact factor: 4.074

Review 10.  Hematopoietic stem cell donation.

Authors:  Shu-Huey Chen; Tso-Fu Wang; Kuo-Liang Yang
Journal:  Int J Hematol       Date:  2013-02-19       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.